Company: SHPH
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001493152-25-002253
Chunk: 68

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-15
Form: S-1
Chunk 68
---
 STOCKHOLDERS</div>

The shares of common stock being offered by the selling stockholders are those issuable to the selling stockholders pursuant to the terms of certain of the Company’s convertible notes and accompanying warrants. For additional information regarding the issuances of those notes and accompanying warrants, see “Private Placement of Senior Secured Convertible Notes and Warrants” above. We are registering the shares of common stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership of the notes and accompanying warrants, the selling shareholders have not had any material relationship with us within the past three years.

The table below lists the selling stockholders and other information regarding the beneficial ownership of our common stock by each of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each selling stockholder, based on its ownership of the notes and accompanying warrants, as of January 13, 2025, assuming the conversion of the notes and accompanying warrants held by the selling stockholders on that date, without regard to any limitations on conversion.

The third column lists the shares of common stock being offered by this prospectus by the selling stockholders. This prospectus generally covers the resale of 200% of the maximum number of shares of common stock issuable upon conversion of the notes, along with the warrants, determined as if the notes and accompanying warrants were converted in full as of the trading day immediately preceding the date this registration statement was initially filed with the Commission, each as of the trading day immediately preceding the applicable date of determination without regard to any limitations on conversion in the notes and accompanying warrants.

The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.

Under the terms of the notes and accompanying warrants, a selling stockholder may not be issued shares under the notes or accompanying warrants to the extent such issuance would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding shares of common stock following such conversion. The number of shares in the second column does not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

| 47 |

| Name of Selling Shareholder |     | Number of Shares Owned Prior to 
 Offering                        |         |    |     | Maximum Number of Shares to be Offered       
 for the